Betamethasone is an inflammation-reducing corticosteroid that helps treat a range of skin conditions. Learn about the types, uses, and side effects of this medication here, as well as the warnings ...

The Food and Drug Administration (FDA) has approved Wynzora® Cream (calcipotriene 0.005% and betamethasone dipropionate 0.064%; MC2 Therapeutics) for the treatment of plaque psoriasis in patients ...

Wynzora ® Cream (calcipotriene 0.005% and betamethasone dipropionate 0.064%) is now available for the topical treatment of plaque psoriasis in adults 18 years of age and older.

Betamethasone dipropionate lotion (augmented), 0.05% had a market value of approximately $10 million for the 12 months ended August 2019, according to IQVIA.

Psoriasis patients treated with a cream formulation of calcipotriene and betamethasone dipropionate developed with PAD technology showed significant improvement over those treated with a ...

* Expect to launch betamethasone dipropionate ointment USP, 0.05% in Q1 of 2018 Source text for Eikon: Further company coverage: Sign up here. Healthcare & Pharmaceuticalscategory Lilly says ...

A novel formulation of calcipotriene (CAL), betamethasone dipropionate (BDP) cream was found to be more effective, provide superior quality of life, and safe in patients with psoriasis, compared ...